Michael Farrell

44PUBLICATIONS
132CO-AUTHORS
Predictive and prognostic markersToxicology (incl. clinical toxicology)Pacific Peoples theory of change models for healthCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jun 12, 2026
Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression.

|Oct 15, 2025
Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000-2025.

Shane Darke, Johan Duflou, Michael Farrell

|Jul 14, 2025
Vaporized Nicotine Products for Smoking Cessation Among People Experiencing Social Disadvantage : A Randomized Clinical Trial.

Ryan J Courtney, Bridget C Howard, Daniel Barker

|Feb 25, 2025
Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study.

Thomas James Santo, Antoine Chaillon, Natasha Martin

|Jan 31, 2025
Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review.

Amelia Woods, Catherine Foley, Katherine M Conigrave

|Dec 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial.

Nadine Ezard, Brendan Clifford, Krista J Siefried

Pageof 8

Frequent Collaborators

15 joint publications

Amy Peacock

15 joint publications

Louisa Degenhardt

13 joint publications

Shane Darke

10 joint publications

Julia M Lappin